Identifying DNA Methylation Modules Associated with a Cancer by Probabilistic Evolutionary Learning
暂无分享,去创建一个
[1] Jie Zhang,et al. Pan-cancer analysis of frequent DNA co-methylation patterns reveals consistent epigenetic landscape changes in multiple cancers , 2017, BMC Genomics.
[2] Byoung-Tak Zhang,et al. Bayesian evolutionary hypergraph learning for predicting cancer clinical outcomes , 2014, J. Biomed. Informatics.
[3] Alexander Mendiburu,et al. A Distance-Based Ranking Model Estimation of Distribution Algorithm for the Flowshop Scheduling Problem , 2014, IEEE Transactions on Evolutionary Computation.
[4] Byoung-Tak Zhang,et al. Integrated analysis of genome-wide DNA methylation and gene expression profiles in molecular subtypes of breast cancer , 2013, Nucleic acids research.
[5] Peter J. Fleming,et al. On finding well-spread pareto optimal solutions by preference-inspired co-evolutionary algorithm , 2013, GECCO '13.
[6] Vaidyanathan K. Jayaraman,et al. Hybrid feature selection and peptide binding affinity prediction using an EDA based algorithm , 2013, 2013 IEEE Congress on Evolutionary Computation.
[7] Xian-hong Liu,et al. RNAi screening identifies KAT8 as a key molecule important for cancer cell survival. , 2013, International journal of clinical and experimental pathology.
[8] Abdullah Al Mamun,et al. Multi-Objective Optimization with Estimation of Distribution Algorithm in a Noisy Environment , 2013, Evolutionary Computation.
[9] Byoung-Tak Zhang,et al. A probabilistic coevolutionary biclustering algorithm for discovering coherent patterns in gene expression dataset , 2012, BMC Bioinformatics.
[10] Martha L Slattery,et al. MAP kinase genes and colon and rectal cancer. , 2012, Carcinogenesis.
[11] Thomas Lengauer,et al. Comparative genome-wide DNA methylation analysis of colorectal tumor and matched normal tissues , 2012, Epigenetics.
[12] S. Horvath,et al. Aging effects on DNA methylation modules in human brain and blood tissue , 2012, Genome Biology.
[13] S. Lipkin,et al. Chemokine 25-induced signaling suppresses colon cancer invasion and metastasis. , 2012, The Journal of clinical investigation.
[14] Peter A. Jones. Functions of DNA methylation: islands, start sites, gene bodies and beyond , 2012, Nature Reviews Genetics.
[15] Adam Kiezun,et al. Exome sequencing and the genetic basis of complex traits , 2012, Nature Genetics.
[16] R. Siebert,et al. Distinct DNA methylation patterns in cirrhotic liver and hepatocellular carcinoma , 2012, International journal of cancer.
[17] A. Shukla,et al. Structure Based Design and Synthesis of Peptide Inhibitor of Human LOX-12: In Vitro and In Vivo Analysis of a Novel Therapeutic Agent for Breast Cancer , 2012, PloS one.
[18] H. Kitchener,et al. The Dynamics and Prognostic Potential of DNA Methylation Changes at Stem Cell Gene Loci in Women's Cancer , 2012, PLoS genetics.
[19] M. Esteller,et al. Cancer epigenomics: beyond genomics. , 2012, Current opinion in genetics & development.
[20] Dvir Aran,et al. Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood. , 2012, Human molecular genetics.
[21] S. Dey,et al. Evaluation of human LOX-12 as a serum marker for breast cancer. , 2011, Biochemical and biophysical research communications.
[22] M. Jauberteau,et al. Fine-Tuning Roles of Endogenous Brain-Derived Neurotrophic Factor, TrkB and Sortilin in Colorectal Cancer Cell Survival , 2011, PloS one.
[23] Helga Thorvaldsdóttir,et al. Molecular signatures database (MSigDB) 3.0 , 2011, Bioinform..
[24] Martin J. Aryee,et al. A DNA hypermethylation module for the stem/progenitor cell signature of cancer , 2011, Genome research.
[25] C. Ricketts,et al. Genome-wide DNA methylation profiling of CpG islands in breast cancer identifies novel genes associated with tumorigenicity. , 2011, Cancer research.
[26] Fiona M Ross,et al. Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma. , 2011, Blood.
[27] Manoj Kumar,et al. Genetic Algorithm: Review and Application , 2010 .
[28] Eleazar Eskin,et al. Multi-marker tagging single nucleotide polymorphism selection using estimation of distribution algorithms , 2010, Artif. Intell. Medicine.
[29] M. Esteller,et al. Epigenetic modifications and human disease , 2010, Nature Biotechnology.
[30] Jason I. Herschkowitz,et al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer , 2010, Breast Cancer Research.
[31] R. Siebert,et al. DNA Methylation Profiles and Their Relationship with Cytogenetic Status in Adult Acute Myeloid Leukemia , 2010, PloS one.
[32] Kalyanmoy Deb,et al. A fast and accurate solution of constrained optimization problems using a hybrid bi-objective and penalty function approach , 2010, IEEE Congress on Evolutionary Computation.
[33] M. Aoki,et al. Inactivation of chemokine (C-C motif) receptor 1 (CCR1) suppresses colon cancer liver metastasis by blocking accumulation of immature myeloid cells in a mouse model , 2010, Proceedings of the National Academy of Sciences.
[34] Brian C. Jackson,et al. Update of human and mouse forkhead box (FOX) gene families , 2010, Human Genomics.
[35] H. Lenz,et al. Vascular endothelial growth factor and epidermal growth factor signaling pathways as therapeutic targets for colorectal cancer. , 2010, Gastroenterology.
[36] P. Laird. Principles and challenges of genome-wide DNA methylation analysis , 2010, Nature Reviews Genetics.
[37] O. Rennert,et al. Genome-wide DNA methylation profiling reveals novel epigenetically regulated genes and non-coding RNAs in human testicular cancer , 2010, British Journal of Cancer.
[38] Y. Dou,et al. Two mammalian MOF complexes regulate transcription activation by distinct mechanisms. , 2009, Molecular cell.
[39] A. Jimeno,et al. Characterizing DNA methylation patterns in pancreatic cancer genome , 2009, Molecular oncology.
[40] Qingfu Zhang,et al. Approximating the Set of Pareto-Optimal Solutions in Both the Decision and Objective Spaces by an Estimation of Distribution Algorithm , 2009, IEEE Transactions on Evolutionary Computation.
[41] Per Kristian Lehre,et al. When is an estimation of distribution algorithm better than an evolutionary algorithm? , 2009, 2009 IEEE Congress on Evolutionary Computation.
[42] E. Lobenhofer,et al. Comparative epigenomics of human and mouse mammary tumors , 2009, Genes, chromosomes & cancer.
[43] Cornelia M van Duijn,et al. Genome-based prediction of common diseases: advances and prospects. , 2008, Human molecular genetics.
[44] L. Cantley,et al. PI3K pathway alterations in cancer: variations on a theme , 2008, Oncogene.
[45] J. Squire,et al. Cause and Consequences of Genetic and Epigenetic Alterations in Human Cancer , 2008, Current genomics.
[46] L. Bonetta. Epigenomics: Detailed analysis , 2008, Nature.
[47] L. Ellis,et al. VEGF-targeted therapy: mechanisms of anti-tumour activity , 2008, Nature Reviews Cancer.
[48] C. Shriver,et al. Identification of a gene expression breast cancer nodal metastasis profile , 2008 .
[49] N. Clarke,et al. Functional epigenomics approach to identify methylated candidate tumour suppressor genes in renal cell carcinoma , 2008, British Journal of Cancer.
[50] Martin Pelikan,et al. Dependency trees, permutations, and quadratic assignment problem , 2007, GECCO '07.
[51] Peter A. Jones,et al. The Epigenomics of Cancer , 2007, Cell.
[52] I. Tomlinson,et al. Colorectal cancer and genetic alterations in the Wnt pathway , 2006, Oncogene.
[53] S. Bandyopadhyay,et al. Evolutionary computation in bioinformatics: a review , 2006, IEEE Transactions on Systems, Man, and Cybernetics, Part C (Applications and Reviews).
[54] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[55] J. Ptak,et al. Colorectal cancer: Mutations in a signalling pathway , 2005, Nature.
[56] K. Robertson. DNA methylation and human disease , 2005, Nature Reviews Genetics.
[57] Jing-Yuan Fang,et al. The MAPK signalling pathways and colorectal cancer. , 2005, The Lancet. Oncology.
[58] G Milano,et al. Epidermal growth factor receptor signaling in colorectal cancer: preclinical data and therapeutic perspectives. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.
[59] M. Daly,et al. Genome-wide association studies for common diseases and complex traits , 2005, Nature Reviews Genetics.
[60] R. Roskoski. The ErbB/HER receptor protein-tyrosine kinases and cancer. , 2004, Biochemical and biophysical research communications.
[61] M. Dowsett,et al. Circulating tumour cells in breast cancer. , 2004, The Lancet. Oncology.
[62] K. Honn,et al. Overexpression of platelet-type 12-lipoxygenase promotes tumor cell survival by enhancing alpha(v)beta(3) and alpha(v)beta(5) integrin expression. , 2003, Cancer research.
[63] K. Honn,et al. Mechanisms controlling cell cycle arrest and induction of apoptosis after 12-lipoxygenase inhibition in prostate cancer cells. , 2002, Cancer research.
[64] X. Ding,et al. Lipoxygenase inhibition induced apoptosis, morphological changes, and carbonic anhydrase expression in human pancreatic cancer cells. , 1999, Biochemical and biophysical research communications.
[65] D. Grimm,et al. Diagnostic and therapeutic use of membrane proteins in cancer cells. , 2011, Current medicinal chemistry.
[66] Sreeram V Ramagopalan,et al. Epigenetics: molecular mechanisms and implications for disease. , 2010, Trends in molecular medicine.
[67] Arnaud Krebs,et al. GPAT: Retrieval of genomic annotation from large genomic position datasets , 2008, BMC Bioinformatics.
[68] K. Honn,et al. Overexpression of Platelet-type 12-Lipoxygenase Promotes Tumor Cell Survival by Enhancing v 3 and v 5 Integrin Expression 1 , 2003 .